Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04149379

Hyperbaric Oxygen Therapy After Stroke - PILOT

Hyperbaric Oxygen Therapy After Cerebral Infarction - PILOT

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Norwegian Underwater Intervention (NUI) · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The goal of this pilot study is to establish more information about hyperbaric oxygen therapy for this group of patients, and give us more information of how to initiate the best possible main study. Can we find any indications that support the use of this therapy for patients suffering from chronic disability after cerebral infarction? Can we improve physical and cognitive function.

Detailed description

This is a pilot project including 6 patients for one session of 20 treatments of hyperbaric oxygen therapy. The objective is to establish knowledge of HBO for this group of patients in a Norwegian context, so that we can prepare for the main study afterwards, including about 60-70 patients. We need to know how to optimize the administrative and technical systems for the larger study. We want to collect feedback from the patients undergoing the pilot study. We want more information about the treatment table, if 20 treatments are enough, if 2,4 bar pressure is adequate. The treatment table is based on existing research, and is considered safe. The patients are to be treated at table 14/90, at 2,4 Absolute atmospheres, and daly 90 minutes of oxygen inhalation (medical oxygen).

Conditions

Interventions

TypeNameDescription
DRUGHyperbaric oxygen20 sessions of hyperbaric therapy in a pressure chamber at 2,4 absolute atmospheres, 90 minutes per day of breathing 100% medical oxygen through an own mask. Table 14/90.

Timeline

Start date
2020-04-20
Primary completion
2021-08-31
Completion
2021-12-20
First posted
2019-11-04
Last updated
2020-04-27

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04149379. Inclusion in this directory is not an endorsement.